Eterna Therapeutics's total assets for Q were $49.66M, an increase of 1.07% from the previous quarter. ERNA total liabilities were $53.07M for the fiscal quarter, a 13.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.